Atara Biotherapeutics, Inc. announced that on March 26, 2024, Eric Dobmeier, a member of the Board of Directors the company, notified the Company of his decision to not stand for re-election to the Board at the Company?s 2024 annual meeting of stockholders (2024 Annual Meeting). Mr. Dobmeier will serve out the remainder of his term as a director, which will expire at the 2024 Annual Meeting. Mr. Dobmeier?s decision to not stand for re-election to the Company?s Board was not the result of any disagreement or dispute with the Board or management of the Company on any matter relating to the Company?s operations, policies or practices.